| Previous Close | 96.53 |
| Open | 96.79 |
| Bid | 90.14 x 100 |
| Ask | 99.81 x 100 |
| Day's Range | 95.56 - 98.04 |
| 52 Week Range | 65.59 - 98.70 |
| Volume | 407,231 |
| Avg. Volume | 387,312 |
| Market Cap | 5.15B |
| Beta | 0.43 |
| PE Ratio (TTM) | 19.89 |
| EPS (TTM) | 4.82 |
| Earnings Date | Jul 24, 2017 - Jul 28, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 94.92 |
- The Wall Street Journal•7 days ago
[$$] Drug-Research Shake Up Continues as Pamplona Reaches Deal to Buy Parexel
Private-equity firm Pamplona has reached a deal to buy Parexel for $4.6 billion, the latest in a series of mergers among drug-research firms.
- Business Wire•12 days ago
ICON and DIA Amplify Thought Leadership and Debate with DIA Live 2017
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that for the second consecutive year it will present DIA Live – a social media aggregation site that allows visitors to track and analyse Twitter conversations from delegates at the DIA 2017 Annual Meeting .
- Investopedia•27 days ago
Historically Strong Stocks in June
These four stocks including Oracle and Infosys have a strong historical tendency to rise in June, often moving up significantly.